Will the Pfizer–BioNTech vaccine be effective against the new N501Y SARS-CoV-2 variant? – News-Medical.Net

While the coronavirus disease 2019 (COVID-19) pandemic continues to wreak havoc in many parts of the world, a new variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged.
This new variant, called N501Y, has caused skyrocketing cases in the UK, where it first emerged in September 2020. To date, the country has reported more than 3.12 million cases and over 82,000 deaths.
The rise of this highly infectious new strain has raised serious questions about whether or not…

Click here to view the original article.